Literature DB >> 11157072

Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy.

R H Christie1, B J Bacskai, W R Zipfel, R M Williams, S T Kajdasz, W W Webb, B T Hyman.   

Abstract

In Alzheimer's disease, amyloid-beta peptide aggregates in the extracellular space to form senile plaques. The process of plaque deposition and growth has been modeled on the basis of in vitro experiments in ways that lead to divergent predictions: either a diffusion-limited growth model in which plaques grow by first-order kinetics, or a dynamic model of continual deposition and asymmetrical clearance in which plaques reach a stable size and stop growing but evolve morphologically over time. The models have not been tested in vivo because plaques are too small (by several orders of magnitude) for conventional imaging modalities. We now report in vivo multiphoton laser scanning imaging of thioflavine S-stained senile plaques in the Tg2576 transgenic mouse model of Alzheimer's disease to test these biophysical models and show that there is no detectable change in plaque size over extended periods of time. Qualitatively, geometric features remain unchanged over time in the vast majority of the 349 plaques imaged and re-imaged. Intervals as long as 5 months were obtained. Nonetheless, rare examples of growth or shrinkage of individual plaques do occur, and new plaques appear between imaging sessions. These results indicate that thioflavine S-positive plaques appear and then are stable, supporting a dynamic feedback model of plaque growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157072      PMCID: PMC6762315     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  19 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Two-photon laser scanning fluorescence microscopy.

Authors:  W Denk; J H Strickler; W W Webb
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

3.  APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

Authors:  M C Irizarry; M McNamara; K Fedorchak; K Hsiao; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1997-09       Impact factor: 3.685

4.  Thioflavin S fluorescent and Congo red anisotropic stainings in the histologic demonstration of amyloid.

Authors:  G Kelényi
Journal:  Acta Neuropathol       Date:  1967-02-03       Impact factor: 17.088

5.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

6.  Dynamics of plaque formation in Alzheimer's disease.

Authors:  B Urbanc; L Cruz; S V Buldyrev; S Havlin; M C Irizarry; H E Stanley; B T Hyman
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

7.  Microglial response to amyloid plaques in APPsw transgenic mice.

Authors:  S A Frautschy; F Yang; M Irrizarry; B Hyman; T C Saido; K Hsiao; G M Cole
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

8.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

Authors:  J P Vonsattel; R H Myers; E T Hedley-Whyte; A H Ropper; E D Bird; E P Richardson
Journal:  Ann Neurol       Date:  1991-11       Impact factor: 10.422

9.  In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.

Authors:  W P Esler; E R Stimson; J R Ghilardi; H V Vinters; J P Lee; P W Mantyh; J E Maggio
Journal:  Biochemistry       Date:  1996-01-23       Impact factor: 3.162

10.  Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.

Authors:  B T Hyman; R E Tanzi; K Marzloff; R Barbour; D Schenk
Journal:  J Neuropathol Exp Neurol       Date:  1992-01       Impact factor: 3.685

View more
  72 in total

1.  In Vivo Microscopy of the Mouse Brain Using Multiphoton Laser Scanning Techniques.

Authors:  Elizabeth J Yoder
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2002-06-17

2.  Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.

Authors:  John F Reilly; Dora Games; Russell E Rydel; Stephen Freedman; Dale Schenk; Warren G Young; John H Morrison; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

3.  Intraocular multiphoton microscopy with subcellular spatial resolution by infrared femtosecond lasers.

Authors:  Bao-Gui Wang; Karsten Koenig; Iris Riemann; Reimar Krieg; Karl-Juergen Halbhuber
Journal:  Histochem Cell Biol       Date:  2006-05-04       Impact factor: 4.304

Review 4.  Optical monitoring of brain function in vivo: from neurons to networks.

Authors:  Olga Garaschuk; Ruxandra-Iulia Milos; Christine Grienberger; Nima Marandi; Helmuth Adelsberger; Arthur Konnerth
Journal:  Pflugers Arch       Date:  2006-10-18       Impact factor: 3.657

5.  Multiphoton imaging can be used for microscopic examination of intact human gastrointestinal mucosa ex vivo.

Authors:  Jason N Rogart; Jun Nagata; Caroline S Loeser; Robert D Roorda; Harry Aslanian; Marie E Robert; Warren R Zipfel; Michael H Nathanson
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12-18       Impact factor: 11.382

6.  Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.

Authors:  Brian J Bacskai; Gregory A Hickey; Jesse Skoch; Stephen T Kajdasz; Yanming Wang; Guo-Feng Huang; Chester A Mathis; William E Klunk; Bradley T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-29       Impact factor: 11.205

7.  Longitudinal in vivo two-photon fluorescence imaging.

Authors:  Sarah E Crowe; Graham C R Ellis-Davies
Journal:  J Comp Neurol       Date:  2014-06-01       Impact factor: 3.215

8.  A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.

Authors:  Marcin Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; James A Ripellino; Yongsheng Li; Stephen D Schmidt; Paul M Mathews; John D Fryer; David M Holtzman; Einar M Sigurdsson; Thomas Wisniewski
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  Intravital imaging of DSS-induced cecal mucosal damage in GFP-transgenic mice using two-photon microscopy.

Authors:  Yuji Toiyama; Akira Mizoguchi; Yoshinaga Okugawa; Yuhki Koike; Yuhki Morimoto; Toshimitsu Araki; Keiichi Uchida; Koji Tanaka; Hisako Nakashima; Mayumi Hibi; Kazushi Kimura; Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2010-01-09       Impact factor: 7.527

10.  Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

Authors:  Brian J Bacskai; Stephen T Kajdasz; Megan E McLellan; Dora Games; Peter Seubert; Dale Schenk; Bradley T Hyman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.